These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Belrose G; Gross A; Olindo S; Lézin A; Dueymes M; Komla-Soukha I; Smadja D; Tanaka Y; Willems L; Mesnard JM; Peloponese JM; Césaire R Blood; 2011 Sep; 118(9):2483-91. PubMed ID: 21505188 [TBL] [Abstract][Full Text] [Related]
23. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814 [TBL] [Abstract][Full Text] [Related]
24. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP. Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR Virol J; 2014 Sep; 11():172. PubMed ID: 25270762 [TBL] [Abstract][Full Text] [Related]
25. HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors. Yasuma K; Matsuzaki T; Yamano Y; Takashima H; Matsuoka M; Saito M J Neurovirol; 2016 Aug; 22(4):416-30. PubMed ID: 26635027 [TBL] [Abstract][Full Text] [Related]
26. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP. Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920 [TBL] [Abstract][Full Text] [Related]
27. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle. Alasiri A; Abboud Guerr J; Hall WW; Sheehy N J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665 [TBL] [Abstract][Full Text] [Related]
28. Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status. Shiohama Y; Naito T; Matsuzaki T; Tanaka R; Tomoyose T; Takashima H; Fukushima T; Tanaka Y; Saito M Retrovirology; 2016 Apr; 13():29. PubMed ID: 27117327 [TBL] [Abstract][Full Text] [Related]
29. Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein. Daian E Silva DSO; Cox LJ; Rocha AS; Lopes-Ribeiro Á; Souza JPC; Franco GM; Prado JLC; Pereira-Santos TA; Martins ML; Coelho-Dos-Reis JGA; Gomes-de-Pinho TM; Da Fonseca FG; Barbosa-Stancioli EF Virol J; 2023 Dec; 20(1):304. PubMed ID: 38115107 [TBL] [Abstract][Full Text] [Related]
31. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining. Rushing AW; Hoang K; Polakowski N; Lemasson I J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340 [TBL] [Abstract][Full Text] [Related]
32. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259 [TBL] [Abstract][Full Text] [Related]
33. HLA class I binding of HBZ determines outcome in HTLV-1 infection. Macnamara A; Rowan A; Hilburn S; Kadolsky U; Fujiwara H; Suemori K; Yasukawa M; Taylor G; Bangham CR; Asquith B PLoS Pathog; 2010 Sep; 6(9):e1001117. PubMed ID: 20886101 [TBL] [Abstract][Full Text] [Related]
34. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546 [TBL] [Abstract][Full Text] [Related]
35. Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. Philip S; Zahoor MA; Zhi H; Ho YK; Giam CZ PLoS Pathog; 2014 Apr; 10(4):e1004040. PubMed ID: 24699669 [TBL] [Abstract][Full Text] [Related]
36. Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice. Mitagami Y; Yasunaga J; Kinosada H; Ohshima K; Matsuoka M PLoS Pathog; 2015 Aug; 11(8):e1005120. PubMed ID: 26296091 [TBL] [Abstract][Full Text] [Related]
37. A vaccine against HTLV-1 HBZ makes sense. Mahieux R Blood; 2015 Aug; 126(9):1052-3. PubMed ID: 26316613 [TBL] [Abstract][Full Text] [Related]
38. HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling. Higuchi Y; Yasunaga JI; Mitagami Y; Tsukamoto H; Nakashima K; Ohshima K; Matsuoka M Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13740-13749. PubMed ID: 32471947 [TBL] [Abstract][Full Text] [Related]
39. HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients. Forlani G; Baratella M; Tedeschi A; Pique C; Jacobson S; Accolla RS Front Microbiol; 2019; 10():819. PubMed ID: 31080441 [TBL] [Abstract][Full Text] [Related]
40. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages. Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]